Tego^™

Needlefree Hemodialysis Connector

Designed to help protect your patients’ catheters from contamination and increased risk of catheter-related bloodstream infections (CRBSIs) during hemodialysis and apheresis applications

Use of Tego was shown to be associated with a 10-12% reduction in CRBSIs.¹
Straight fluid path accommodates flow rates of > 600 mL/min.
Validated for continuous patient use for up to 7 days.

Help protect your patients’ hemodialysis catheters from contamination and minimize the risk of CRBSIs

The Tego needlefree hemodialysis connector creates a closed system when attached to the hub of a catheter to minimize contamination and help reduce the risk of CRBSIs. Tego’s saline flush option is designed to help reduce the risk of heparin-induced thrombocytopenia (HIT) and helps you minimize overall hemodialysis costs by reducing heparin use.^2-3

Functional Attributes

Straight fluid path accommodates flow rates of greater than 600 mL/min
Remains in place during the entire hemodialysis treatment period
Validated for continuous patient use for up to 7 days
Silicone seal remains closed when not activated, closing the fluid path

Clinical Advantages

Use of Tego was shown to be associated with a 10-12% reduction in CRBSIs¹
Tego is a needle-free capping device which closes the end of a hemodialysis catheter, creating a mechanically closed system, prohibiting microbial ingress when attached to the hub of a hemodialysis catheter. Tego will permit access to the catheter without the use of needles, and therefore passively aid in the reduction of needlestick injuries.
Tego's saline flush option helps to reduce risks and costs associated with heparin use.

Accessing the Fluid Path:

When Tego is not being accessed, the silicone seal forms a swabbable barrier to bacterial ingress.
Attaching a dialysis bloodline to Tego activates the straight internal fluid path and creates a mechanically closed system, prohibiting microbial ingress.

Product information

Product Literature

Supporting Evidence

Product Reference

Attach the Tego to Patient’s Catheter

Use aseptic technique to remove Tego from package
Prime Tego in accordance with facility procedure/protocol
Remove cap and attach Tego to desired vascular access device

Swab the Tego Before Each Access

Swab the silicone seal of Tego before each use in accordance with facility protocol
Do not use needles, blunt cannulas, or luer-type caps to access Tego

Access the Tego

Attach administration devices or syringes by pushing straight into Tego access devices for infusions When using a luer slip connection, only insert half way while turning slightly clockwise.
When removing, apply the same clockwise turning motion. Do not overtighten.

Flush the Tego

Clamp line before disconnecting from Tego and between dialysis sessions per established clinical and catheter manufacturer’s practices
Dispose of device in accordance with facility protocol

Precautions: Device should be changed in accordance with current, recognized guidelines of IV therapy. Tego has been validated for functional and microbiological efficacy for up to seven days.

In-Service Video

Product Inquiry

Please enter your details into the following form.

Comments *

Please do not enter any patient data

First name *

Last name *

Email address *

References

Brunelli SM, Njord L, Hunt AE, Sibbel SP. Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients. Int J Nephrol Renovasc Dis. 2014; 7: 131–139.
Farthing, C et al. Tego connectors reduce heparin use without affecting blood flow rate compared to traditional central venous catheter locks. American Nephrology Nurses Association 43rd National Symposium, Orlando, FL, Apr 29-May 2, 2012.
Krishnan M et al. Tego connectors reduce heparin use without affecting blood flow rate compared to traditional central venous catheter locks. American Society of Nephrology Kidney Week. Philadelphia, PA, Nov 8-11, 2011.

Tego™